Latest Insider Transactions at Sleep Number Corp (SNBR)
This section provides a real-time view of insider transactions for Sleep Number Corp (SNBR). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Sleep Number Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Sleep Number Corp's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 10
2024
|
Deborah L. Kilpatrick Director |
BUY
Bona fide gift
|
Indirect |
132
+0.52%
|
-
|
|
Dec 10
2024
|
Deborah L. Kilpatrick Director |
SELL
Bona fide gift
|
Direct |
132
-2.36%
|
-
|
|
Dec 10
2024
|
Deborah L. Kilpatrick Director |
BUY
Grant, award, or other acquisition
|
Direct |
132
+2.31%
|
$2,508
$19.71 P/Share
|
|
Nov 18
2024
|
Stadium Capital Management LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
15,000
+0.67%
|
$180,000
$12.12 P/Share
|
|
Nov 15
2024
|
Stadium Capital Management LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
11,540
+0.26%
|
$150,020
$13.04 P/Share
|
|
Nov 14
2024
|
Stadium Capital Management LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
16,600
+0.75%
|
$215,800
$13.73 P/Share
|
|
Nov 13
2024
|
Stadium Capital Management LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
22,000
+1.0%
|
$286,000
$13.86 P/Share
|
|
Nov 12
2024
|
Stadium Capital Management LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
29,860
+1.37%
|
$418,040
$14.22 P/Share
|
|
Nov 11
2024
|
Stadium Capital Management LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
25,325
+1.18%
|
$354,550
$14.9 P/Share
|
|
Nov 06
2024
|
Stadium Capital Management LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
400
+0.01%
|
$5,600
$14.47 P/Share
|
|
Nov 05
2024
|
Stadium Capital Management LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
39,473
+0.93%
|
$513,149
$13.84 P/Share
|
|
Nov 04
2024
|
Stadium Capital Management LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
36,097
+1.73%
|
$469,261
$13.09 P/Share
|
|
Nov 01
2024
|
Stadium Capital Management LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
98,705
+2.37%
|
$1,283,165
$13.35 P/Share
|
|
Oct 31
2024
|
Stadium Capital Management LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
59,011
+1.51%
|
$767,143
$13.47 P/Share
|
|
Sep 18
2024
|
Deborah L. Kilpatrick Director |
BUY
Bona fide gift
|
Indirect |
133
+0.53%
|
-
|
|
Sep 18
2024
|
Deborah L. Kilpatrick Director |
SELL
Bona fide gift
|
Direct |
133
-2.38%
|
-
|
|
Sep 18
2024
|
Deborah L. Kilpatrick Director |
BUY
Grant, award, or other acquisition
|
Direct |
133
+2.32%
|
$2,527
$19.59 P/Share
|
|
Sep 05
2024
|
Christopher D Krusmark EVP & Chief H.R. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
890
-2.74%
|
$12,460
$14.23 P/Share
|
|
Aug 15
2024
|
Francis K Lee EVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,000
-6.13%
|
$36,000
$12.17 P/Share
|
|
Aug 06
2024
|
Stephen E. Macadam Director |
BUY
Open market or private purchase
|
Direct |
43,000
+29.51%
|
$516,000
$12.35 P/Share
|
|
May 21
2024
|
Angel L Mendez Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,457
+30.1%
|
-
|
|
May 21
2024
|
Julie Howard Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,457
+18.96%
|
-
|
|
May 21
2024
|
Deborah L. Kilpatrick Director |
BUY
Bona fide gift
|
Indirect |
170
+0.68%
|
-
|
|
May 21
2024
|
Deborah L. Kilpatrick Director |
SELL
Bona fide gift
|
Direct |
170
-3.02%
|
-
|
|
May 21
2024
|
Deborah L. Kilpatrick Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,627
+26.47%
|
$39,389
$7.67 P/Share
|
|
May 21
2024
|
Brenda J Lauderback Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,457
+10.9%
|
-
|
|
May 21
2024
|
Stephen E. Macadam Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,457
+8.37%
|
-
|
|
May 21
2024
|
Barbara Ruth Matas Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,457
+14.72%
|
-
|
|
May 21
2024
|
Hilary Schneider Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,457
+35.93%
|
-
|
|
May 21
2024
|
Daniel Alegre Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,549
+5.21%
|
$23,235
$15.33 P/Share
|
|
May 21
2024
|
Phillip Eyler Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,457
+30.1%
|
-
|
|
May 21
2024
|
Stephen L Gulis Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,457
+12.4%
|
-
|
|
May 21
2024
|
Michael J Harrison Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,457
+28.25%
|
-
|
|
May 11
2024
|
Deborah L. Kilpatrick Director |
BUY
Bona fide gift
|
Indirect |
4,195
+14.45%
|
-
|
|
May 11
2024
|
Deborah L. Kilpatrick Director |
SELL
Bona fide gift
|
Direct |
4,195
-100.0%
|
-
|
|
Mar 15
2024
|
Christopher D Krusmark EVP & Chief H.R. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,459
+15.6%
|
-
|
|
Mar 15
2024
|
Christopher D Krusmark EVP & Chief H.R. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
732
-3.31%
|
$9,516
$13.53 P/Share
|
|
Mar 15
2024
|
Shelly Radue Ibach President and CEO |
BUY
Bona fide gift
|
Indirect |
14,146
+4.85%
|
-
|
|
Mar 15
2024
|
Shelly Radue Ibach President and CEO |
SELL
Bona fide gift
|
Direct |
14,146
-7.33%
|
-
|
|
Mar 15
2024
|
Shelly Radue Ibach President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
105,092
+22.09%
|
-
|
|
Mar 15
2024
|
Samuel R Hellfeld EVP Chief Legal & Risk Officer |
BUY
Grant, award, or other acquisition
|
Direct |
23,190
+18.87%
|
-
|
|
Mar 15
2024
|
Kevin Kennedy Brown EVP and CMO |
BUY
Grant, award, or other acquisition
|
Direct |
15,351
+11.71%
|
-
|
|
Mar 15
2024
|
Kevin Kennedy Brown EVP and CMO |
SELL
Payment of exercise price or tax liability
|
Direct |
932
-2.16%
|
$12,116
$13.53 P/Share
|
|
Mar 15
2024
|
Andrea Lee Bloomquist EVP, Chief Innovation Officer |
BUY
Grant, award, or other acquisition
|
Direct |
22,530
+9.22%
|
-
|
|
Mar 15
2024
|
Andrea Lee Bloomquist EVP, Chief Innovation Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
818
-0.93%
|
$10,634
$13.53 P/Share
|
|
Mar 15
2024
|
Melissa Barra EVP, Chief Sales & Services |
BUY
Grant, award, or other acquisition
|
Direct |
22,468
+11.29%
|
-
|
|
Mar 15
2024
|
Melissa Barra EVP, Chief Sales & Services |
SELL
Payment of exercise price or tax liability
|
Direct |
1,138
-1.73%
|
$14,794
$13.53 P/Share
|
|
Mar 15
2024
|
Joel Joseph Laing Treasurer & CAO |
BUY
Grant, award, or other acquisition
|
Direct |
3,779
+15.03%
|
-
|
|
Mar 15
2024
|
Joel Joseph Laing Treasurer & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
338
-2.77%
|
$4,394
$13.53 P/Share
|
|
Mar 15
2024
|
Joseph Hunter Saklad EVP, Chief Supply Chain Office |
BUY
Grant, award, or other acquisition
|
Direct |
15,351
+10.19%
|
-
|